These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21356044)

  • 21. Cyclooxygenases expression and distribution in the normal ovary and their role in ovarian cancer in the domestic hen (Gallus domesticus).
    Hales DB; Zhuge Y; Lagman JA; Ansenberger K; Mahon C; Barua A; Luborsky JL; Bahr JM
    Endocrine; 2008 Jun; 33(3):235-44. PubMed ID: 18498063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression.
    Kitano M; Hla T; Sekiguchi M; Kawahito Y; Yoshimura R; Miyazawa K; Iwasaki T; Sano H; Saba JD; Tam YY
    Arthritis Rheum; 2006 Mar; 54(3):742-53. PubMed ID: 16508938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of Ovarian Tumor Detection by DR6-Targeted Ultrasound Imaging Agents in Laying Hen Model of Spontaneous Ovarian Cancer.
    Barua A; Edassery SL; McNeal S; Bahr JM; Bitterman P; Basu S; Sharma S; Abramowicz JS
    Int J Gynecol Cancer; 2016 Oct; 26(8):1375-85. PubMed ID: 27465898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type 1 sphingosine 1-phosphate G protein-coupled receptor signaling of lymphocyte functions requires sulfation of its extracellular amino-terminal tyrosines.
    Fieger CB; Huang MC; Van Brocklyn JR; Goetzl EJ
    FASEB J; 2005 Nov; 19(13):1926-8. PubMed ID: 16148028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.
    Shiow LR; Rosen DB; Brdicková N; Xu Y; An J; Lanier LL; Cyster JG; Matloubian M
    Nature; 2006 Mar; 440(7083):540-4. PubMed ID: 16525420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PPARγ agonists upregulate sphingosine 1-phosphate (S1P) receptor 1 expression, which in turn reduces S1P-induced [Ca(2+)]i increases in renal mesangial cells.
    Koch A; Völzke A; Puff B; Blankenbach K; Meyer Zu Heringdorf D; Huwiler A; Pfeilschifter J
    Biochim Biophys Acta; 2013 Nov; 1831(11):1634-43. PubMed ID: 23906789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-9 Promotes Angiogenesis via Targeting on Sphingosine-1- Phosphate Receptor 1.
    Yao X; Xie L; Zeng Y
    Front Cell Dev Biol; 2020; 8():755. PubMed ID: 32850858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and localization of growth hormone and its receptors in the chicken ovary during sexual maturation.
    Hrabia A; Paczoska-Eliasiewicz HE; Berghman LR; Harvey S; Rzasa J
    Cell Tissue Res; 2008 May; 332(2):317-28. PubMed ID: 18335240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S1P lyase in thymic perivascular spaces promotes egress of mature thymocytes via up-regulation of S1P receptor 1.
    Maeda Y; Yagi H; Takemoto K; Utsumi H; Fukunari A; Sugahara K; Masuko T; Chiba K
    Int Immunol; 2014 May; 26(5):245-55. PubMed ID: 24343820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
    Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
    Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients.
    Watson C; Long JS; Orange C; Tannahill CL; Mallon E; McGlynn LM; Pyne S; Pyne NJ; Edwards J
    Am J Pathol; 2010 Nov; 177(5):2205-15. PubMed ID: 20889557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VEGFR2-Targeted Ultrasound Imaging Agent Enhances the Detection of Ovarian Tumors at Early Stage in Laying Hens, a Preclinical Model of Spontaneous Ovarian Cancer.
    Barua A; Yellapa A; Bahr JM; Machado SA; Bitterman P; Basu S; Sharma S; Abramowicz JS
    Ultrason Imaging; 2015 Jul; 37(3):224-37. PubMed ID: 25294846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
    Chiba K; Matsuyuki H; Maeda Y; Sugahara K
    Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice.
    Tarrasón G; Aulí M; Mustafa S; Dolgachev V; Domènech MT; Prats N; Domínguez M; López R; Aguilar N; Calbet M; Pont M; Milligan G; Kunkel SL; Godessart N
    Int Immunopharmacol; 2011 Nov; 11(11):1773-9. PubMed ID: 21798372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of fibroblast growth factor (FGF)-8 isoforms and FGF receptors in human ovarian tumors.
    Valve E; Martikainen P; Seppänen J; Oksjoki S; Hinkka S; Anttila L; Grenman S; Klemi P; Härkönen P
    Int J Cancer; 2000 Dec; 88(5):718-25. PubMed ID: 11072239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis.
    Jin J; Hu J; Zhou W; Wang X; Xiao Q; Xue N; Yin D; Chen X
    Biochem Pharmacol; 2014 Jul; 90(1):50-61. PubMed ID: 24780445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S1P1 receptor expression regulates emergence of NKT cells in peripheral tissues.
    Allende ML; Zhou D; Kalkofen DN; Benhamed S; Tuymetova G; Borowski C; Bendelac A; Proia RL
    FASEB J; 2008 Jan; 22(1):307-15. PubMed ID: 17785606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of gonadotropin-releasing hormone receptor and its mRNA in primary human epithelial ovarian cancers.
    Chien CH; Chen CH; Lee CY; Chang TC; Chen RJ; Chow SN
    Int J Gynecol Cancer; 2004; 14(3):451-8. PubMed ID: 15228417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric parietal cell atrophy and depletion after administration of a sphingosine-1-phosphate 1 inhibitor.
    Radi ZA; Vogel MW
    Toxicol Pathol; 2014 Jan; 42(1):118-23. PubMed ID: 24178572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes.
    Singer II; Tian M; Wickham LA; Lin J; Matheravidathu SS; Forrest MJ; Mandala S; Quackenbush EJ
    J Immunol; 2005 Dec; 175(11):7151-61. PubMed ID: 16301618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.